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Abstract Hospital-wide active surveillance for methicil-
lin-resistant Staphylococcus aureus (MRSA) targeted to
adult patients with a history of MRSA carriage within
the past 5 years was performed in Juntendo University
Hospital (JUH) over a 2-year period. In the ﬁrst year,
MRSA screening culture was ordered by physicians in
charge. In the second year, infection-control practitioners
(ICPs) took samples for active surveillance culture. The
average monthly transmission rate of MRSA in JUH was
0.35 per 1,000 bed-days in the ﬁrst year and decreased
signiﬁcantly to 0.26 per 1,000 bed-days in the second year
(P\ 0.05). In the second year, more active commitment of
ICPs to MRSA screening was effective in improving the
performance rate of screening, shortening turn-around time
of screening results, and decreasing transmission rate.
Increasing compliance with active MRSA surveillance by
involvement of ICPs, targeting patients with a previous
history of MRSA carriage in the previous 5 years, was
effective to control nosocomial MRSA transmission.
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Introduction
Since its discovery in 1961 [1], methicillin-resistant
Staphylococcus aureus (MRSA) has remained a major
nosocomial pathogen throughout the world, causing grave
clinical and ﬁnancial problems in healthcare facilities [2].
Implementation of contact precautions for MRSA carriers
is essential for preventing its nosocomial spread, so early
detection of newly hospitalized patients carrying MRSA is
a critical issue [3]. Active surveillance culture (AS-C) for
MRSA has been conducted in Juntendo University Hospital
(JUH) since 2006 for hospitalized patients having a history
of MRSA carriage in the past 5 years. While waiting for
the results of screening culture, healthcare workers
(HCWs) followed a pre-emptive contact precaution policy,
but the efﬁcacy of this policy has not been evaluated.
We postulated that a shorter turnaround time (TAT) of
screening results could be expected by more active
involvement of infection-control practitioners (ICPs) and
shorter TAT might cause higher compliance to implement
the contact precaution policy and to reduce nosocomial
transmission of MRSA.
In this study, we analyzed the effect of our active
surveillance practice on the rate of horizontal MRSA
transmission in the hospital, especially of the commitment
of ICPs to active MRSA screening.
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Patients and methods
Study setting and periods
JUH is a large, 1,020-bed teaching hospital with an average
hospital stay of 13.2 days. All adult wards (922 beds) were
included in this study. The study periods were divided into
two phases: January–December 2009 (phase 1), and Janu-
ary–December 2010 (phase 2).
Candidates for active surveillance of MRSA
and screening procedures
AS-C was conducted in both phases of the study. All
patients with a history of MRSA carriage in the last 5 years
were candidates for AS-C on admission. The following
patients were excluded: (1) those who had history of con-
ﬁrmed MRSA carriage/infection within 14 days before
admission (regarded as MRSA carriers on admission); (2)
those previously assigned as MRSA carriers but who had at
least three successive negative culture results from anterior
nares and other body sites on three separate days before
admission (regarded as ex-carriers); and (3) patients who
declined to participate in the study (regarded as MRSA
carrier throughout their hospitalization). Electronic medical
records of patients with a past history of MRSA carriage
were ﬂagged automatically on admission. In phase 1, nasal
culture for MRSA screening was ordered by physicians in
charge when they recognized that their new patients had a
history of MRSA carriage. For patients admitted at nights
or on holidays, physicians in charge ordered screening
culture on earliest business days after their admission.
In phase 2, ICPs identiﬁed candidates for AS-C from
electronic medical records of scheduled admission cases
1 day before admission. On admission, ICPs immediately
visited inpatients’ rooms to obtain nasal swabs. In cases of
urgent admissions or admissions on holidays, patients were
screened by ICPs on the day after their admission. Speci-
mens were taken from patients’ anterior nares using sterile
cotton swabs moistened with saline. The swab sample was
streaked onto MRSA screening agar (CHROMagarTM
MRSA; CHROMagar Microbiology, Paris, France) [4] and
incubated at 35 C for 48 h. When colonies were found on
screening agar, the patient was regarded as a MRSA car-
rier. The culture results were returned to HCWs in charge
via electronic hospital medical charts.
Infection-control policies, isolation, and compliance
monitoring
The usual contact precaution policy was implemented
immediately after admission of all candidates for AS-C
while awaiting culture results. Isolation in single rooms
was encouraged if they were available, and the patients
agreed with isolation. Contact precaution and isolation
policy was continued if the ﬁrst culture on admission
revealed the presence of MRSA or the candidate did not
participate in AS-C. When the ﬁrst culture was negative,
two additional cultures of anterior nares and cultures from
another body sites where MRSA had been positive previ-
ously were taken by physicians in charge. If all additional
cultures were negative, screening candidates were released
from isolation. Average days from admission to conﬁr-
mation of culture results were calculated as TAT in phase 1
and phase 2. Use of alcohol hand rub (AHR) was moni-
tored monthly throughout all adult wards in phase 1 and
phase 2 as an indirect indicator of compliance with hand-
hygiene procedures for preventing MRSA nosocomial
transmission. In order to examine the effect of AHR on the
transmission rate, the entire study period was also divided
into four subphases: phases 1a (6 months from January to
June 2009), 1b (6 months from July to December 2009), 2a
(5 months from January to May 2010), and 2b (7 months
from June to December 2010).
MRSA transmission rate
An event of MRSA transmission was deﬁned as a positive
culture obtained for the ﬁrst time later than 48 h after
admission. The monthly transmission rate was calculated
as the number of MRSA transmission events in all adult
wards, divided by the number of bed-days. The outcome
was calculated as the average monthly transmission rate
and expressed as events per 1,000 bed-days.
Statistical analysis
Data analysis was performed with the Mann–Whitney
U test or the chi-square test using Excel (Microsoft Cor-
poration, USA). Values of P\ 0.05 were considered as
signiﬁcant difference.
Ethical disclosure
This study was approved by the ethical committee of JUH
with the approval number 21–84. Written informed consent
was obtained from all participants.
Results
Implementation of active surveillance culture
Table 1 shows the results of implementation of AS-C in
phases 1 and 2. A total of 239 patients were enrolled for AS
(1.12 % of 21,399 annual admissions) in phase 1 and 255
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(1.16 % of 22,070 annual admissions) in phase 2. How-
ever, AS-C was performed on only 179 (74.9 % of 239)
patients enrolled in phase 1, and execution of AS-C
increased signiﬁcantly to 235 (92.2 % of 255) in phase 2
(P\ 0.01). Percentage of MRSA-positive patients in all
patients who underwent AS-C in phase 1 was 38.0 % (68
of 179) and increased signiﬁcantly to 54.5 % (128 of 235)
in phase 2, respectively (P\ 0.01). Average TAT was
3.45 days in phase 1 and improved signiﬁcantly to
2.97 days in phase 2 (P\ 0.001, Table 1).
MRSA transmission rate and related factors
The average monthly transmission rate of MRSA was 0.35
(0.079–0.62) per 1,000 bed-days in phase 1 and decreased
signiﬁcantly to 0.26 (0.078–0.38) in phase 2 (P\ 0.05,
Table 1). The average monthly consumption of AHR also
signiﬁcantly increased in phase 2 (12,894 ml) compared
with phase 1 (10,308 ml) (P\ 0.05, Table 1).
Comparison of MRSA nosocomial transmission rates
between each intervention subphase and the change of
AHR consumption is shown in Fig. 1. The average MRSA
transmission rate gradually decreased throughout the entire
study period, although the transmission rates in each sub-
phase were not statistically different. This tendency was
not in accord with the average consumption of AHR.
The number of candidates allocated to single-room iso-
lation on hospital admission was 153 in phase 1 and 181 in
phase 2. The percentage of candidates who were isolated
appropriately showed no statistically signiﬁcant difference
in different phases of the study: 153/239 in phase 1 (64.0 %)
versus 181/255 in phase 2 (71.0 %) (P = 0.098, Table 1).
Discussion
This study was conducted to investigate the effectiveness
of an active screening culture policy to reduce MRSA
Table 1 Comparison of parameters in phases 1 and 2
Comparison individuals Phase 1 Phase 2 P value
No. of patients admitted in all adult wards in each phase 21,399 22,070 –
No. of candidates for screening (% of total admitted patients) 239 (1.12 %) 255 (1.16 %) 0.705
Active surveillance culture (AS-C)
Percentage of eligible patients screened in candidates for screening 74.9 % 92.2 % \0.001
No. of MRSA-positive patients (% in all patients who underwent AS-C) 68 (38.0 %) 128 (54.5 %) \0.001
Average turnaround time (TAT) from admission (mean ± SD) 3.45 ± 1.48 days 2.97 ± 1.18 days \0.001
Average monthly consumption of alcohol hand rubs (mean ± SD) 10,308 ± 1,411 ml 12,894 ± 2,627 ml \0.05
Percentage of candidates allocated to single-room isolation on admission 64.0 % 71.0 % 0.098
Monthly transmission rate of MRSA (mean ± SD, per 1,000 patient days) 0.35 ± 0.16 0.26 ± 0.08 \0.05
MRSA methicillin-resistant Staphylococcus aureus, SD standard deviation, AS-C active surveillance culture
Fig. 1 Comparison of average monthly transmission rate of methi-
cillin-resistant Staphylococcus aureus (MRSA) per 1,000 bed-days
and average monthly consumption of alcohol hand rubs (AHRs)
between four subphases. Bar graphs show average monthly trans-
mission rate of MRSA per 1,000 bed-days. A line graph shows total
consumption of AHR per month in adult wards of Juntendo
University Hospital. The transmission rates in each subphase were
not statistically different. Average consumption of AHR was signif-
icantly different between phases 1a and 1b (P\ 0.05) and between
phase 2a and 2b (P\ 0.01)
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transmission rate in JUH. A retrospective review of MRSA
carriers hospitalized in 2005, a year with no surveillance
culture and isolation policy, showed that 67 of 69 carriers
(97.1 %) had history ofMRSA carriage or infectionwithin the
past 5 years (Hori, unpublished data). From this result, we
decided to target patients who had episodes ofMRSA carriage
or infection within the past 5 years as candidates for AS-C
instead of indicating universal screening for all admissions.
The rate of MRSA transmission signiﬁcantly decreased
during phase 2 of this study. Between the two phases, four
other important differences were observed: the larger
number of at-risk patients screened; the higher rate of
detection of MRSA-positive patients; the shorter TAT of
culture results; and the higher consumption rate of AHR.
These differences, except for the increase in AHR use,
seem most likely to be due to involvement of ICPs to the
ﬁrst AS-C. ICPs were able to identify enrolled patients
prior to admission and performed subsequent sampling
during phase 2. Immediate visit and sampling by ICPs after
admission contributed to the lower omission rate of
screening, and the number of screened patients increased in
phase 2. Adequate and standardized procedures to obtain
culture samples and shorter time from sampling to begin-
ning laboratory incubation are generally important to
increase positivity culture rates. Therefore, sampling by
ICPs and shorter TAT may have contributed to the higher
rate of MRSA-positive patients in phase 2, although it is
possible that more MRSA carriers were included by chance
in phase 2; also, screened patients could not be released
from isolation until two additional culture results were
negative. In addition, ICP visits may have encouraged
HCWs in charge to more strictly implement infection-
control procedures after patient admission.
In May 2010, a project to encourage AHR use was con-
ducted in the hospital by giving awards to wards that dem-
onstrated excellent compliance with the policy. During this
project, the use of AHR rose from 10,188 to 14,826 ml
(P\ 0.01); however, the monthly MRSA transmission rates
did not signiﬁcantly change (0.27 vs. 0.26 per 1,000 bed-
days, P[ 0.05). Monitoring total AHR consumption is
considered one of the indicators to measure compliance of
hand hygiene procedure in hospitals [5], and this study
raised the possibility that improved compliance with hand
hygiene was one cause for the decrease in MRSA trans-
mission rate. However, correlation between AHR con-
sumption and MRSA transmission rate was unclear in
comparison with shorter subphases in this study. Other
factors besides infection control for MRSA could increase
the use of AHR, so the effect of increasing AHR con-
sumption needs to be investigated in the future. Similarly,
single-room isolation on admission did not seem to con-
tribute to a decrease in MRSA transmission between phases
1 and 2 of this study, so other factors appear to be involved.
The efﬁciency of AS-C depends on the prevalence of
MRSA carriers. Although complete surveillance would
potentially detect all carriers, universal screening of all
hospitalized patients is not practical in terms of cost
effectiveness [2, 6]. A signiﬁcant merit of our screening
policy is that it is conducted on only about 1 % of patients
admitted and yet has a signiﬁcant impact on MRSA
transmission rate in the hospital. MRSA carriage rates
among patients who underwent AS-C were as high as 38.0
and 54.5 % in phase 1 and 2 studies (Table 1). In hospital-
wide universal screening, the prevalence of MRSA among
patients on admission was reported as only 2.7–7.5 %
[7–9]. Therefore, our screening policy was highly effective
in detecting MRSA carriers despite the small number of
patients screened.
A limitation of this study was that the correct horizontal
transmission rate in the hospital could not be analyzed, as
we neither did universal screening covering all hospital
wards nor had all MRSA strains isolated in this hospital.
Cases transferred from other hospitals were excluded as
candidates for AS-C in this study but clearly represent a
risk factor for MRSA import to JUH.
In conclusion, active MRSA surveillance targeting of
patients with a history of MRSA carriage within the previous
5 years was highly effective in detecting MRSA carriers on
admission. Increasing compliance with screening these high-
risk patients by active involvement of ICPs was effective in
controlling nosocomial MRSA transmission.
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